nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—Drug fever—Spironolactone—dilated cardiomyopathy	0.0366	0.0723	CcSEcCtD
Nortriptyline—CYP2C9—cardial valve—dilated cardiomyopathy	0.0196	0.368	CbGeAlD
Nortriptyline—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.0189	0.0372	CcSEcCtD
Nortriptyline—Indecainide—SCN5A—dilated cardiomyopathy	0.0162	0.607	CrCbGaD
Nortriptyline—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.0109	0.0216	CcSEcCtD
Nortriptyline—SLC6A2—sympathetic nervous system—dilated cardiomyopathy	0.0106	0.199	CbGeAlD
Nortriptyline—Appetite absent—Lisinopril—dilated cardiomyopathy	0.01	0.0198	CcSEcCtD
Nortriptyline—Cholestasis—Furosemide—dilated cardiomyopathy	0.00876	0.0173	CcSEcCtD
Nortriptyline—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00859	0.0169	CcSEcCtD
Nortriptyline—Ataxia—Spironolactone—dilated cardiomyopathy	0.00835	0.0165	CcSEcCtD
Nortriptyline—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0076	0.015	CcSEcCtD
Nortriptyline—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00739	0.0146	CcSEcCtD
Nortriptyline—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00707	0.0139	CcSEcCtD
Nortriptyline—Throat sore—Lisinopril—dilated cardiomyopathy	0.00693	0.0137	CcSEcCtD
Nortriptyline—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00686	0.0135	CcSEcCtD
Nortriptyline—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00684	0.0135	CcSEcCtD
Nortriptyline—HTR2A—pulmonary artery—dilated cardiomyopathy	0.00653	0.123	CbGeAlD
Nortriptyline—Oxcarbazepine—SCN5A—dilated cardiomyopathy	0.00652	0.245	CrCbGaD
Nortriptyline—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00652	0.0129	CcSEcCtD
Nortriptyline—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00638	0.0126	CcSEcCtD
Nortriptyline—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.00635	0.119	CbGeAlD
Nortriptyline—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00625	0.0123	CcSEcCtD
Nortriptyline—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00549	0.0108	CcSEcCtD
Nortriptyline—Alopecia—Spironolactone—dilated cardiomyopathy	0.00543	0.0107	CcSEcCtD
Nortriptyline—Vascular purpura—Furosemide—dilated cardiomyopathy	0.0054	0.0106	CcSEcCtD
Nortriptyline—Purpura—Furosemide—dilated cardiomyopathy	0.00501	0.00988	CcSEcCtD
Nortriptyline—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00499	0.00985	CcSEcCtD
Nortriptyline—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00496	0.00978	CcSEcCtD
Nortriptyline—Malaise—Spironolactone—dilated cardiomyopathy	0.00482	0.00951	CcSEcCtD
Nortriptyline—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00479	0.00944	CcSEcCtD
Nortriptyline—Irritability—Furosemide—dilated cardiomyopathy	0.00461	0.00909	CcSEcCtD
Nortriptyline—Urinary retention—Furosemide—dilated cardiomyopathy	0.00459	0.00906	CcSEcCtD
Nortriptyline—Discomfort—Spironolactone—dilated cardiomyopathy	0.0045	0.00887	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00441	0.0087	CcSEcCtD
Nortriptyline—Confusional state—Spironolactone—dilated cardiomyopathy	0.0044	0.00868	CcSEcCtD
Nortriptyline—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00427	0.00843	CcSEcCtD
Nortriptyline—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00415	0.00818	CcSEcCtD
Nortriptyline—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00413	0.00815	CcSEcCtD
Nortriptyline—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00391	0.00771	CcSEcCtD
Nortriptyline—Somnolence—Spironolactone—dilated cardiomyopathy	0.00388	0.00765	CcSEcCtD
Nortriptyline—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00386	0.00761	CcSEcCtD
Nortriptyline—Drowsiness—Furosemide—dilated cardiomyopathy	0.00372	0.00734	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.0037	0.00729	CcSEcCtD
Nortriptyline—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0036	0.00709	CcSEcCtD
Nortriptyline—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00359	0.00709	CcSEcCtD
Nortriptyline—Sweating—Furosemide—dilated cardiomyopathy	0.00357	0.00704	CcSEcCtD
Nortriptyline—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00347	0.00685	CcSEcCtD
Nortriptyline—Urticaria—Spironolactone—dilated cardiomyopathy	0.00347	0.00684	CcSEcCtD
Nortriptyline—Irritability—Lisinopril—dilated cardiomyopathy	0.00346	0.00682	CcSEcCtD
Nortriptyline—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00345	0.0068	CcSEcCtD
Nortriptyline—Ataxia—Lisinopril—dilated cardiomyopathy	0.00341	0.00672	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00331	0.00653	CcSEcCtD
Nortriptyline—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00321	0.00634	CcSEcCtD
Nortriptyline—Eye disorder—Furosemide—dilated cardiomyopathy	0.00312	0.00616	CcSEcCtD
Nortriptyline—Tinnitus—Furosemide—dilated cardiomyopathy	0.00311	0.00614	CcSEcCtD
Nortriptyline—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.0031	0.00612	CcSEcCtD
Nortriptyline—Pruritus—Spironolactone—dilated cardiomyopathy	0.00309	0.00609	CcSEcCtD
Nortriptyline—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00305	0.00602	CcSEcCtD
Nortriptyline—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00299	0.00589	CcSEcCtD
Nortriptyline—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00298	0.00589	CcSEcCtD
Nortriptyline—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00297	0.00587	CcSEcCtD
Nortriptyline—Dizziness—Spironolactone—dilated cardiomyopathy	0.00289	0.00569	CcSEcCtD
Nortriptyline—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00288	0.00569	CcSEcCtD
Nortriptyline—Weight increased—Lisinopril—dilated cardiomyopathy	0.00285	0.00562	CcSEcCtD
Nortriptyline—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00285	0.00562	CcSEcCtD
Nortriptyline—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00283	0.00559	CcSEcCtD
Nortriptyline—Vomiting—Spironolactone—dilated cardiomyopathy	0.00277	0.00547	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00275	0.00543	CcSEcCtD
Nortriptyline—Rash—Spironolactone—dilated cardiomyopathy	0.00275	0.00543	CcSEcCtD
Nortriptyline—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00275	0.00542	CcSEcCtD
Nortriptyline—Vision blurred—Furosemide—dilated cardiomyopathy	0.00274	0.00541	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00274	0.0054	CcSEcCtD
Nortriptyline—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00274	0.0054	CcSEcCtD
Nortriptyline—Headache—Spironolactone—dilated cardiomyopathy	0.00273	0.00539	CcSEcCtD
Nortriptyline—Jaundice—Lisinopril—dilated cardiomyopathy	0.00272	0.00537	CcSEcCtD
Nortriptyline—Sweating—Lisinopril—dilated cardiomyopathy	0.00268	0.00528	CcSEcCtD
Nortriptyline—Agitation—Furosemide—dilated cardiomyopathy	0.00267	0.00527	CcSEcCtD
Nortriptyline—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00261	0.00514	CcSEcCtD
Nortriptyline—Leukopenia—Furosemide—dilated cardiomyopathy	0.0026	0.00514	CcSEcCtD
Nortriptyline—Nausea—Spironolactone—dilated cardiomyopathy	0.00259	0.00511	CcSEcCtD
Nortriptyline—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00251	0.00494	CcSEcCtD
Nortriptyline—Hallucination—Lisinopril—dilated cardiomyopathy	0.00249	0.00492	CcSEcCtD
Nortriptyline—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00247	0.00487	CcSEcCtD
Nortriptyline—Dry mouth—Furosemide—dilated cardiomyopathy	0.00242	0.00478	CcSEcCtD
Nortriptyline—Confusional state—Furosemide—dilated cardiomyopathy	0.00239	0.00472	CcSEcCtD
Nortriptyline—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00234	0.00461	CcSEcCtD
Nortriptyline—Shock—Furosemide—dilated cardiomyopathy	0.00234	0.00461	CcSEcCtD
Nortriptyline—Flushing—Lisinopril—dilated cardiomyopathy	0.00233	0.00459	CcSEcCtD
Nortriptyline—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00232	0.00458	CcSEcCtD
Nortriptyline—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00229	0.00453	CcSEcCtD
Nortriptyline—Anorexia—Furosemide—dilated cardiomyopathy	0.00226	0.00446	CcSEcCtD
Nortriptyline—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00224	0.00442	CcSEcCtD
Nortriptyline—Hypotension—Furosemide—dilated cardiomyopathy	0.00222	0.00438	CcSEcCtD
Nortriptyline—Alopecia—Lisinopril—dilated cardiomyopathy	0.00222	0.00437	CcSEcCtD
Nortriptyline—Tension—Lisinopril—dilated cardiomyopathy	0.00214	0.00422	CcSEcCtD
Nortriptyline—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00214	0.00422	CcSEcCtD
Nortriptyline—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00213	0.0042	CcSEcCtD
Nortriptyline—Nervousness—Lisinopril—dilated cardiomyopathy	0.00212	0.00418	CcSEcCtD
Nortriptyline—Somnolence—Furosemide—dilated cardiomyopathy	0.00211	0.00416	CcSEcCtD
Nortriptyline—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00206	0.00407	CcSEcCtD
Nortriptyline—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00206	0.00406	CcSEcCtD
Nortriptyline—Fatigue—Furosemide—dilated cardiomyopathy	0.00205	0.00404	CcSEcCtD
Nortriptyline—Tremor—Lisinopril—dilated cardiomyopathy	0.00204	0.00403	CcSEcCtD
Nortriptyline—Constipation—Furosemide—dilated cardiomyopathy	0.00203	0.004	CcSEcCtD
Nortriptyline—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00202	0.00399	CcSEcCtD
Nortriptyline—Malaise—Lisinopril—dilated cardiomyopathy	0.00197	0.00388	CcSEcCtD
Nortriptyline—Syncope—Lisinopril—dilated cardiomyopathy	0.00196	0.00386	CcSEcCtD
Nortriptyline—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00196	0.00386	CcSEcCtD
Nortriptyline—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00195	0.00385	CcSEcCtD
Nortriptyline—Palpitations—Lisinopril—dilated cardiomyopathy	0.00193	0.0038	CcSEcCtD
Nortriptyline—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00192	0.00378	CcSEcCtD
Nortriptyline—Urticaria—Furosemide—dilated cardiomyopathy	0.00189	0.00372	CcSEcCtD
Nortriptyline—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00188	0.0037	CcSEcCtD
Nortriptyline—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00188	0.0037	CcSEcCtD
Nortriptyline—Anxiety—Lisinopril—dilated cardiomyopathy	0.00185	0.00365	CcSEcCtD
Nortriptyline—CHRM2—heart—dilated cardiomyopathy	0.00184	0.0346	CbGeAlD
Nortriptyline—Discomfort—Lisinopril—dilated cardiomyopathy	0.00184	0.00362	CcSEcCtD
Nortriptyline—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00182	0.00358	CcSEcCtD
Nortriptyline—Confusional state—Lisinopril—dilated cardiomyopathy	0.0018	0.00354	CcSEcCtD
Nortriptyline—Oedema—Lisinopril—dilated cardiomyopathy	0.00178	0.00351	CcSEcCtD
Nortriptyline—Shock—Lisinopril—dilated cardiomyopathy	0.00175	0.00346	CcSEcCtD
Nortriptyline—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00175	0.00345	CcSEcCtD
Nortriptyline—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00174	0.00344	CcSEcCtD
Nortriptyline—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00174	0.00343	CcSEcCtD
Nortriptyline—Desipramine—SLC22A5—dilated cardiomyopathy	0.00174	0.0652	CrCbGaD
Nortriptyline—ALB—heart—dilated cardiomyopathy	0.00173	0.0326	CbGeAlD
Nortriptyline—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00172	0.0034	CcSEcCtD
Nortriptyline—Asthenia—Furosemide—dilated cardiomyopathy	0.0017	0.00336	CcSEcCtD
Nortriptyline—Anorexia—Lisinopril—dilated cardiomyopathy	0.0017	0.00335	CcSEcCtD
Nortriptyline—Pruritus—Furosemide—dilated cardiomyopathy	0.00168	0.00331	CcSEcCtD
Nortriptyline—Hypotension—Lisinopril—dilated cardiomyopathy	0.00166	0.00328	CcSEcCtD
Nortriptyline—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00162	0.0032	CcSEcCtD
Nortriptyline—Insomnia—Lisinopril—dilated cardiomyopathy	0.00161	0.00318	CcSEcCtD
Nortriptyline—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.0016	0.00315	CcSEcCtD
Nortriptyline—Somnolence—Lisinopril—dilated cardiomyopathy	0.00158	0.00312	CcSEcCtD
Nortriptyline—Dizziness—Furosemide—dilated cardiomyopathy	0.00157	0.0031	CcSEcCtD
Nortriptyline—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00157	0.00309	CcSEcCtD
Nortriptyline—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00155	0.00305	CcSEcCtD
Nortriptyline—Fatigue—Lisinopril—dilated cardiomyopathy	0.00154	0.00303	CcSEcCtD
Nortriptyline—Constipation—Lisinopril—dilated cardiomyopathy	0.00152	0.003	CcSEcCtD
Nortriptyline—Vomiting—Furosemide—dilated cardiomyopathy	0.00151	0.00298	CcSEcCtD
Nortriptyline—Rash—Furosemide—dilated cardiomyopathy	0.0015	0.00295	CcSEcCtD
Nortriptyline—Dermatitis—Furosemide—dilated cardiomyopathy	0.0015	0.00295	CcSEcCtD
Nortriptyline—Headache—Furosemide—dilated cardiomyopathy	0.00149	0.00293	CcSEcCtD
Nortriptyline—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00147	0.00289	CcSEcCtD
Nortriptyline—PTGS1—myocardium—dilated cardiomyopathy	0.00142	0.0266	CbGeAlD
Nortriptyline—Urticaria—Lisinopril—dilated cardiomyopathy	0.00141	0.00279	CcSEcCtD
Nortriptyline—Nausea—Furosemide—dilated cardiomyopathy	0.00141	0.00278	CcSEcCtD
Nortriptyline—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00141	0.00278	CcSEcCtD
Nortriptyline—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00141	0.00278	CcSEcCtD
Nortriptyline—ADRA1A—heart—dilated cardiomyopathy	0.00138	0.0259	CbGeAlD
Nortriptyline—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00131	0.00259	CcSEcCtD
Nortriptyline—Asthenia—Lisinopril—dilated cardiomyopathy	0.00128	0.00252	CcSEcCtD
Nortriptyline—Pruritus—Lisinopril—dilated cardiomyopathy	0.00126	0.00249	CcSEcCtD
Nortriptyline—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00122	0.0024	CcSEcCtD
Nortriptyline—Desipramine—ADRB1—dilated cardiomyopathy	0.0012	0.045	CrCbGaD
Nortriptyline—Dizziness—Lisinopril—dilated cardiomyopathy	0.00118	0.00232	CcSEcCtD
Nortriptyline—Vomiting—Lisinopril—dilated cardiomyopathy	0.00113	0.00223	CcSEcCtD
Nortriptyline—Rash—Lisinopril—dilated cardiomyopathy	0.00112	0.00222	CcSEcCtD
Nortriptyline—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00112	0.00221	CcSEcCtD
Nortriptyline—Headache—Lisinopril—dilated cardiomyopathy	0.00112	0.0022	CcSEcCtD
Nortriptyline—CYP2C9—heart—dilated cardiomyopathy	0.00108	0.0203	CbGeAlD
Nortriptyline—Nausea—Lisinopril—dilated cardiomyopathy	0.00106	0.00209	CcSEcCtD
Nortriptyline—Desipramine—ADRB2—dilated cardiomyopathy	0.00101	0.0379	CrCbGaD
Nortriptyline—PTGS1—heart—dilated cardiomyopathy	0.000988	0.0186	CbGeAlD
Nortriptyline—HTR2A—heart—dilated cardiomyopathy	0.000892	0.0168	CbGeAlD
Nortriptyline—PTGS1—cardiac atrium—dilated cardiomyopathy	0.000845	0.0159	CbGeAlD
Nortriptyline—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.65e-05	0.000209	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.65e-05	0.000209	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.61e-05	0.000208	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.61e-05	0.000208	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.55e-05	0.000207	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.53e-05	0.000206	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.48e-05	0.000205	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.42e-05	0.000204	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.4e-05	0.000203	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.37e-05	0.000203	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.35e-05	0.000202	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.31e-05	0.000201	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.29e-05	0.000201	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.26e-05	0.0002	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.25e-05	0.0002	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.24e-05	0.000199	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.24e-05	0.000199	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.24e-05	0.000199	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.12e-05	0.000196	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.04e-05	0.000195	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.04e-05	0.000195	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.02e-05	0.000194	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	8e-05	0.000194	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.98e-05	0.000193	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	7.92e-05	0.000192	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.9e-05	0.000191	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.89e-05	0.000191	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	7.88e-05	0.000191	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.87e-05	0.000191	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	7.87e-05	0.00019	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.85e-05	0.00019	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.82e-05	0.000189	CbGpPWpGaD
Nortriptyline—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.8e-05	0.000189	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.79e-05	0.000189	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.77e-05	0.000188	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.75e-05	0.000188	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.75e-05	0.000187	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.73e-05	0.000187	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.7e-05	0.000186	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.66e-05	0.000185	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.66e-05	0.000185	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.63e-05	0.000185	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.6e-05	0.000184	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.6e-05	0.000184	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	7.55e-05	0.000183	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.54e-05	0.000182	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.52e-05	0.000182	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.5e-05	0.000181	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.47e-05	0.000181	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.47e-05	0.000181	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.47e-05	0.000181	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.46e-05	0.00018	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.46e-05	0.00018	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.43e-05	0.00018	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.43e-05	0.00018	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.43e-05	0.00018	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.42e-05	0.00018	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.41e-05	0.000179	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.41e-05	0.000179	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.4e-05	0.000179	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.38e-05	0.000179	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.34e-05	0.000178	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.34e-05	0.000178	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.33e-05	0.000177	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.32e-05	0.000177	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.32e-05	0.000177	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.28e-05	0.000176	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.28e-05	0.000176	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.24e-05	0.000175	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.17e-05	0.000173	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.15e-05	0.000173	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.13e-05	0.000172	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.1e-05	0.000172	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.09e-05	0.000172	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.06e-05	0.000171	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.04e-05	0.00017	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.02e-05	0.00017	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.01e-05	0.00017	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7e-05	0.000169	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	6.96e-05	0.000168	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.95e-05	0.000168	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.93e-05	0.000168	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.91e-05	0.000167	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.91e-05	0.000167	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.89e-05	0.000167	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	6.85e-05	0.000166	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.84e-05	0.000166	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	6.83e-05	0.000165	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.82e-05	0.000165	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	6.81e-05	0.000165	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.8e-05	0.000165	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	6.79e-05	0.000164	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.73e-05	0.000163	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	6.72e-05	0.000163	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.71e-05	0.000163	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.71e-05	0.000162	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	6.7e-05	0.000162	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.69e-05	0.000162	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.67e-05	0.000161	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.65e-05	0.000161	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—RAC1—dilated cardiomyopathy	6.62e-05	0.00016	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.62e-05	0.00016	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.62e-05	0.00016	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.61e-05	0.00016	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.59e-05	0.000159	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.38e-05	0.000154	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.34e-05	0.000153	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—AGT—dilated cardiomyopathy	6.32e-05	0.000153	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.31e-05	0.000153	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.31e-05	0.000153	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.28e-05	0.000152	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—RAC1—dilated cardiomyopathy	6.24e-05	0.000151	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.22e-05	0.000151	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.22e-05	0.000151	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	6.17e-05	0.000149	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.06e-05	0.000147	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.01e-05	0.000145	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—CD36—dilated cardiomyopathy	6.01e-05	0.000145	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	5.98e-05	0.000145	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AGT—dilated cardiomyopathy	5.97e-05	0.000144	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—RAF1—dilated cardiomyopathy	5.94e-05	0.000144	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.84e-05	0.000141	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.75e-05	0.000139	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.73e-05	0.000139	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.72e-05	0.000138	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	5.71e-05	0.000138	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.7e-05	0.000138	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.64e-05	0.000137	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.63e-05	0.000136	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	5.62e-05	0.000136	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.54e-05	0.000134	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.5e-05	0.000133	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.47e-05	0.000132	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	5.47e-05	0.000132	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.45e-05	0.000132	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.45e-05	0.000132	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.44e-05	0.000132	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.42e-05	0.000131	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.42e-05	0.000131	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—AGT—dilated cardiomyopathy	5.41e-05	0.000131	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.41e-05	0.000131	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.4e-05	0.000131	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	5.37e-05	0.00013	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.35e-05	0.00013	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.34e-05	0.000129	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—CD36—dilated cardiomyopathy	5.33e-05	0.000129	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.24e-05	0.000127	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.16e-05	0.000125	CbGpPWpGaD
Nortriptyline—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.15e-05	0.000125	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.09e-05	0.000123	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	4.9e-05	0.000119	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	4.87e-05	0.000118	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.83e-05	0.000117	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.81e-05	0.000116	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—AGT—dilated cardiomyopathy	4.8e-05	0.000116	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.76e-05	0.000115	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.75e-05	0.000115	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.74e-05	0.000115	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.73e-05	0.000114	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.71e-05	0.000114	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.69e-05	0.000113	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	4.68e-05	0.000113	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.67e-05	0.000113	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	4.67e-05	0.000113	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.66e-05	0.000113	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.66e-05	0.000113	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	4.66e-05	0.000113	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.65e-05	0.000113	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.65e-05	0.000112	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	4.61e-05	0.000112	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.6e-05	0.000111	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.6e-05	0.000111	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	4.6e-05	0.000111	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.59e-05	0.000111	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	4.49e-05	0.000109	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	4.48e-05	0.000108	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	4.46e-05	0.000108	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—RAF1—dilated cardiomyopathy	4.39e-05	0.000106	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.33e-05	0.000105	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	4.3e-05	0.000104	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	4.23e-05	0.000102	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.22e-05	0.000102	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.21e-05	0.000102	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	4.2e-05	0.000102	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	4.16e-05	0.000101	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	4.14e-05	0.0001	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—RAF1—dilated cardiomyopathy	4.14e-05	0.0001	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	4.11e-05	9.95e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	4.04e-05	9.79e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	4.04e-05	9.78e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	4.04e-05	9.77e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	4.03e-05	9.76e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	4.02e-05	9.74e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	4.01e-05	9.7e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	3.97e-05	9.61e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	3.96e-05	9.6e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—GPX1—dilated cardiomyopathy	3.96e-05	9.58e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	3.96e-05	9.58e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CD36—dilated cardiomyopathy	3.86e-05	9.33e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.77e-05	9.13e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.75e-05	9.08e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	3.73e-05	9.02e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.59e-05	8.69e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	3.56e-05	8.6e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AGT—dilated cardiomyopathy	3.47e-05	8.4e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	3.46e-05	8.38e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.31e-05	8.01e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	3.27e-05	7.91e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.26e-05	7.89e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.25e-05	7.87e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	3.25e-05	7.86e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	3.24e-05	7.85e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.24e-05	7.84e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	3.23e-05	7.82e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.23e-05	7.82e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.2e-05	7.74e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.19e-05	7.72e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	3.18e-05	7.71e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	3.16e-05	7.64e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	3.12e-05	7.54e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	3.09e-05	7.49e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—EGFR—dilated cardiomyopathy	3.01e-05	7.28e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.87e-05	6.94e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	2.85e-05	6.9e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	2.84e-05	6.88e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—EGFR—dilated cardiomyopathy	2.84e-05	6.87e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.81e-05	6.79e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.8e-05	6.78e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.79e-05	6.76e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	2.78e-05	6.73e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	2.77e-05	6.7e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	2.76e-05	6.67e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.75e-05	6.65e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	2.72e-05	6.58e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	2.7e-05	6.53e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	2.56e-05	6.19e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	2.43e-05	5.88e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.23e-05	5.39e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	2.22e-05	5.36e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.14e-05	5.17e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	2.12e-05	5.13e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.08e-05	5.04e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.96e-05	4.73e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.92e-05	4.66e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.92e-05	4.65e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.91e-05	4.63e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.91e-05	4.62e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.89e-05	4.57e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.88e-05	4.56e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.87e-05	4.54e-05	CbGpPWpGaD
